Related Experiment Video
Updated: Apr 21, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Pediatric critical care physician-administered procedural sedation using propofol: a report from the Pediatric
Pradip P Kamat1, Courtney E McCracken, Scott E Gillespie
11Department of Pediatrics, Emory University School of Medicine, Atlanta, GA. 2Division of Pediatric Critical Care Medicine, Emory University School of Medicine, Atlanta, GA. 3Department of Anesthesiology, Boston Children's Hospital, Boston, MA.
Insights
Pediatric critical care physicians can safely administer propofol for procedural sedation in children, with a low incidence of adverse events. This study highlights their effectiveness across various settings, ensuring successful procedure completion.
Area of Science:
- Pediatric Critical Care Medicine
- Anesthesiology
- Pharmacology
Background:
- Increasing demand for pediatric procedural sedation necessitates expanded provision by pediatric critical care physicians.
- Experience with pediatric critical care physicians administering procedural sedation is not well-documented.
- Propofol is increasingly used for pediatric procedural sedation.
Purpose of the Study:
- To evaluate the multicenter experience of pediatric critical care physicians administering propofol for procedural sedation.
- To identify risk factors associated with adverse events during pediatric procedural sedation.
- To assess the safety and efficacy of propofol in pediatric procedural sedation.
Main Methods:
- A retrospective review of the Pediatric Sedation Research Consortium database (2007-2012).
- Inclusion of data from 91,189 pediatric procedural sedations administered by pediatric critical care physicians.
- Multivariable logistic regression analysis to identify risk factors for adverse events.
Main Results:
- Most sedations (80.9%) occurred in dedicated sedation or radiology units, with 99.9% successful procedure completion.
- Overall adverse event incidence was 5.0%, including airway obstruction (1.6%) and desaturation (1.5%).
- Risk factors for adverse events included sedation location, adjunctive medications, patient diagnoses, and American Society of Anesthesiologists status.
Conclusions:
- Pediatric procedural sedation with propofol administered by pediatric critical care physicians is effective.
- The incidence of adverse events is low, demonstrating a favorable safety profile.
- Pediatric critical care physicians are capable of providing high-quality procedural sedation across diverse settings.
Objective:
Increasing demand for pediatric procedural sedation has resulted in a marked increase in provision of pediatric procedural sedation by pediatric critical care physicians both inside and outside of the ICU. Reported experience of pediatric critical care physicians-administered pediatric procedural sedation is limited. We used the Pediatric Sedation Research Consortium database to evaluate a multicenter experience with propofol by pediatric critical care physicians in all settings.
Setting:
Review of national Pediatric Sedation Research Consortium database to identify pediatric procedural sedation provided by pediatric critical care physicians from 2007 to 2012. Demographic and clinical data were collected to describe pediatric procedural sedation selection, location, and delivery. Multivariable logistic regression analysis was performed to identify risk factors associated with pediatric procedural sedation-related adverse events and complications.
Measurements And Main Results:
A total of 91,189 pediatric procedural sedation performed by pediatric critical care physicians using propofol were included in the database. Median age was 60.0 months (range, 0-264 months; interquartile range, 34.0-132.0); 81.9% of patients were American Society of Anesthesiologists class I or II. Most sedations were performed in dedicated sedation or radiology units (80.9%). Procedures were successfully completed in 99.9% of patients. A propofol bolus alone was used in 52.8%, and 41.7% received bolus plus continuous infusion. Commonly used adjunctive medications were lidocaine (35.3%), opioids (23.3%), and benzodiazepines (16.4%). Overall adverse event incidence was 5.0% (95% CI, 4.9-5.2%), which included airway obstruction (1.6%), desaturation (1.5%), coughing (1.0%), and emergent airway intervention (0.7%). No deaths occurred; a single cardiac arrest was reported in a 13-month-old child receiving propofol and ketamine, with no untoward neurologic sequelae. Risk factors associated with adverse event included: location of sedation, number of adjunctive medications, upper and lower respiratory diagnosis, prematurity diagnosis, weight, American Society of Anesthesiologists status, and painful procedure.
Conclusions:
Pediatric procedural sedation using propofol can be provided by pediatric critical care physicians effectively and with a low incidence of adverse events.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Stages of General Anesthesia
Drug Dosing: Infants and Children
Depolarizing Blockers: Pharmocokinetics
Tracheostomy Suctioning I: Pre-Procedural Steps
Equipment Required
First, gather all necessary equipment: a sterile suction catheter, a sterile disposable container, sterile gloves, a towel or...